Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
View/ Open
Date
2017-08-01ICR Author
Author
Conti, DV
Wang, K
Sheng, X
Bensen, JT
Hazelett, DJ
Cook, MB
Ingles, SA
Kittles, RA
Strom, SS
Rybicki, BA
Nemesure, B
Isaacs, WB
Stanford, JL
Zheng, W
Sanderson, M
John, EM
Park, JY
Xu, J
Stevens, VL
Berndt, SI
Huff, CD
Wang, Z
Yeboah, ED
Tettey, Y
Biritwum, RB
Adjei, AA
Tay, E
Truelove, A
Niwa, S
Sellers, TA
Yamoah, K
Murphy, AB
Crawford, DC
Gapstur, SM
Bush, WS
Aldrich, MC
Cussenot, O
Petrovics, G
Cullen, J
Neslund-Dudas, C
Stern, MC
Jarai, Z-K
Govindasami, K
Chokkalingam, AP
Hsing, AW
Goodman, PJ
Hoffmann, T
Drake, BF
Hu, JJ
Clark, PE
Van Den Eeden, SK
Blanchet, P
Fowke, JH
Casey, G
Hennis, AJM
Han, Y
Lubwama, A
Thompson, IM
Leach, R
Easton, DF
Schumacher, F
Van den Berg, DJ
Gundell, SM
Stram, A
Wan, P
Xia, L
Pooler, LC
Mohler, JL
Fontham, ETH
Smith, GJ
Taylor, JA
Srivastava, S
Eeles, RA
Carpten, J
Kibel, AS
Multigner, L
Parent, M-E
Menegaux, F
Cancel-Tassin, G
Klein, EA
Brureau, L
Stram, DO
Watya, S
Chanock, SJ
Witte, JS
Blot, WJ
Henderson, BE
Haiman, CA
PRACTICAL/ELLIPSE Consortium,
Type
Journal Article
Metadata
Show full item recordAbstract
Prostate cancer incidence is 1.6-fold higher in African Americans than in other populations. The risk factors that drive this disparity are unknown and potentially consist of social, environmental, and genetic influences. To investigate the genetic basis of prostate cancer in men of African ancestry, we performed a genome-wide association meta-analysis using two-sided statistical tests in 10 202 case subjects and 10 810 control subjects. We identified novel signals on chromosomes 13q34 and 22q12, with the risk-associated alleles found only in men of African ancestry (13q34: rs75823044, risk allele frequency = 2.2%, odds ratio [OR] = 1.55, 95% confidence interval [CI] = 1.37 to 1.76, P = 6.10 × 10-12; 22q12.1: rs78554043, risk allele frequency = 1.5%, OR = 1.62, 95% CI = 1.39 to 1.89, P = 7.50 × 10-10). At 13q34, the signal is located 5' of the gene IRS2 and 3' of a long noncoding RNA, while at 22q12 the candidate functional allele is a missense variant in the CHEK2 gene. These findings provide further support for the role of ancestry-specific germline variation in contributing to population differences in prostate cancer risk.
Collections
Subject
PRACTICAL/ELLIPSE Consortium
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 22
Humans
Prostatic Neoplasms
Genetic Predisposition to Disease
Case-Control Studies
Gene Frequency
Polymorphism, Single Nucleotide
African Continental Ancestry Group
Male
Genome-Wide Association Study
Insulin Receptor Substrate Proteins
Genetic Loci
Checkpoint Kinase 2
Research team
Oncogenetics
Language
eng
Date accepted
2017-04-04
License start date
2017-08
Citation
Journal of the National Cancer Institute, 2017, 109 (8)
Publisher
OXFORD UNIV PRESS INC